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The possibility of evaluating the ratio between aldosterone and atrial
natriuretic peptide (ANP) instead of the two hormones by themselves in
studying sodium handling in normal pregnancy and in preeclampsia in
the steady state and following albumin infusion was examined in this
study, In 32 normal pregnancies monitored monthly, the highest aldo-
sterone/ANP ratio was observed in the last weeks (28.7 12), and
dropped in the first postpartum week (3.6 2.8), without changes in
fractional excretion of sodium. In 18 preeclamptic patients, the ratio
was significantly lower than in normal pregnancy at the same gesta-
tional ages, and it was coupled with absolute reduction in the sodium
excretion. Among preeclamptic patients, a significant inverse correla-
tion (P < 0.025) was revealed between the ratio and sodium excretion.
Natriuresis in response to acute volume expansion with albumin
infusion occurred only in 50% of preeclamptic patients, and was
associated with an ANP increase, an aldosterone decrease, and a
further decrease in the ratio. A blunted natriuresis was observed in
cases with a particularly low prealbumin value of this ratio. Further-
more, in preeclampsia, a particularly low ratio seemed to be typical of
the patients who showed poorer placental flows and fetal outcomes.
These results suggest that the balance between aldosterone and ANP
may be a useful index in understanding sodium homeostasis in these
settings.
Volume modifications are central physiopathological features
in normal pregnancy and in preeclampsia. While adequate
plasma volume expansion may be an important feature for
optimal maternal and pennatal outcome, the occurrence of
inadequate plasma volume expansion has been linked to spe-
cific complications of pregnancy such as intrauterine growth
retardation, premature labor, oligohydramnios, chronic hyper-
tension and preeclampsia [1—51.
In normal pregnancy, though plasma volume is increased and
some 600 to 900 mEq of sodium is retained, it is still debatable
if the new condition is "sensed" as an overfill or underfill state
[1]. In preeclampsia, much research documents relative hypo-
volemia in comparison with normal pregnancy [2—5], but it is
not definitively stated whether the plasma volume contraction
precedes or follows vasoconstriction.
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In view of the important role of atrial natnuretic peptide
(ANP) in volume homeostasis, it was hoped that ANP kinetics
could contribute to the understanding of plasma volume
changes through a simple blood analysis rather than through
more complicated procedures. In fact, in physiological condi-
tions, plasma volume changes and ANP are directly related,
and consequently, in these settings, the main stimuli to ANP
release seem to be volume-dependent in response to increased
atrial pressure [6].
However, in normal pregnancy the ANP behavior shows
conflicting results, and it does not seem to be directly related to
plasma volume expansion [7—12]. Furthermore, though plasma
volume and central venous pressure are reduced in preeclamp-
sia (PE), plasma ANP concentrations have surprisingly been
reported as normal [121 or increased [13—161, with the highest
values in the patients with more severe PE [13].
Because many correlations do exist between ANP and the
renin-angiotensin-aldosterone system, and the two hormonal
systems seem to work in tandem to control volume homeostasis
[17], we planned to simultaneously measure ANP and aldoste-
rone levels both in a prospective study in normal pregnancies
and in the steady state of PE, together with the evaluation of
solutes excretion.
In PE, plasma volume expansion has been advocated as a
therapeutic approach in an attempt to improve tissue perfusion
(compromised by intravascular volume contraction) and to
interrupt the pathogenetic chain of relative hypovolemia and
increased peripheral vascular resistances. An antihypertensive
effect of this maneuver has been reported to be associated with
partial reversal of the disturbance of fluid distribution [3]; until
now, no data regarding the effects on ANP and aldosterone
levels or sodium excretion have been available. Thus, because
it would be interesting to assess the changes of the levels of
these two hormones in relationship to the acute volume changes
and the natriuretic response following albumin infusion, we
undertook to measure these parameters in preeclamptic pa-
tients also after acute volume expansion by albumin infusion.
The aim of this study was to examine whether the relationship
between aldosterone and ANP was useful in understanding
sodium excretion and, putatively, volume homeostasis in nor-
mal pregnancy and in PE.
908
Stratta et a!: Aldosterone and ANP in pregnancy 909
Methods
The study was undertaken on 32 normal pregnancies (mean
age 25.8 7, range 19 to 37 years) monitored monthly, and on
18 cases of PE (mean age 36.2 8, range 18 to 44 years)
diagnosed according to the criteria of The American College of
Obstetricians and Gynecologists. All these patients (including
13 nulliparas) had systolic (176 22 mm Hg) and diastolic (108
9.9 mm Hg) hypertension, elevated serum uric acid levels
(6.1 1.3 mgldl )and reduced serum albumin (29 15 g/liter).
Blood creatinine values and proteinuria ranged from 0.4 to 1.3
mgldl and from 0.8 to 7.6 g/24 hr, respectively. The mean
platelet count was 213 100 x l09/liter. No significant alter-
ations in liver enzymes were observed. The preeclamptic
patients were monitored from diagnosis until birth.
Normal pregnant women were on free sodium intake (ranging
from 50 to 341 mEq/day) and hospitalized preeclamptic patients
were on no dietary sodium restriction (mean value 154 mEq/
day).
Albumin infusion
In preeclamptic patients, 20% human serum albumin poor in
salt was infused in a dose of 0.4 glkg over 120 minutes. All
patients gave informed consent, and the procedure was ap-
proved by the Health Administration. Urine collections were
carried out for three hours before the albumin infusion, again at
the end of the albumin infusion and during an additional
two-hour recovery period. Blood samples were taken at the
start (T0) and the end of the albumin infusion (T1) and again at
the end of the recovery period two hours after (T2).
Radioimmunoassays were used for measuring plasma con-
centrations of ANP (RIA-Peninsula) and aldosterone (RIA
Travenol). Aprotinin (5000 kallikrein inactivation U/mI) was
added to blood specimens for ANP determination at the mo-
ment of sampling in order to deactivate the aminopeptidase
enzymes circulating in the plasma, and further procedures were
performed with unextracted samples. Recovery of ANP from
plasma was 98 and 92% in normal pregnant and preeclamptic
women, respectively. Intraassay and interassay variations were
4% and 13%, respectively. Plasma and urine osmolality was
measured with a freezing point osmometer. Calculations of
clearances (Car, Cosm, CH20) and fractional excretion of sodium
(FENa) were made using conventional formulas. Uteroplacental
and fetoplacental blood flows in preeclamptic patients were
measured with a continuous wave ultrasound doppler (Doptek
9012). Normal values are <0.41 (RI) and <3.5 (A/B), respec-
tively [18, 19]. APGAR values were calculated by conventional
formulas.
Statistics
Values were given as mean SD. Student's t-test for paired
and unpaired data, and Fisher's test were used for statistical
evaluation.
Results
In normal pregnancy, aldosterone was considerably in-
creased in the first weeks (Fig. 1). The increment continued
slightly in the second trimester and accelerated in the last weeks
until birth, while there was a brisk fall in the normal range in the
first postpartum days. Conversely, ANP was below the normal
Fig. 1. Aldosterone (•----•) and ANP (• U) kinetics in normal
pregnancy at dfferent gestational ages and in the first post-partum
week. The broken area shows the non-pregnant normal range.
values of age-matched and sex-matched controls (30 6 pg/ml,
N = 30) in the first trimester, rose to a peak near the beginning
of the third, slowly decreased until term, (though remaining in
normal range) and slightly increased after birth (Fig. 1). Except
for the two first determinations (P < 0.05), ANP levels were not
significantly different from normal, while aldosterone levels
were always significantly different from normal (P < 0.01).
The aldosterone/ANP ratios at the same gestational ages
were 20.5 8, 17.8 7, 14.6 6, 15.8 5, 19.1 6,21.4 7
and 28.7 12, respectively, with the highest ratios in the first
and last weeks. FENa ranged from 0.57 0.20 to 0.60 20
without significant differences. The ratio in the early post-
partum period was significantly reduced with respect to all the
determinations of pregnancy (3.6 2.8), while FENa remained
unchanged. In preeclamptic patients, aldosterone levels were
always significantly reduced (Table 1), while ANP levels
showed large variations, and, though the mean value was not
significantly different from normal pregnancies, many single
determinations were increased. The aldosterone/ANP ratio,
total urinary sodium and potassium excretion, Csm and CH20
were significantly reduced in preeclamptic patients, while FENa
was significantly reduced only in late PE.
Among PE, early cases (25 to 29 weeks) showed a signifi-
cantly lower ratio (P < 0.05) coupled with both a significantly
higher (P < 0.05) UNaV and lower (P < 0.05) UKV with respect
to late cases (>35 weeks).
Albumin infusion was performed in 12 cases. In six cases
there was a diuretic and natriuretic response, while in the other
six there was no increase in urine output and solute excretion.
The responders showed a significant increase of ANP and both
a significant aldosterone and ratio decrease (Fig. 2A, left
column). In the non-responders, ANP increased slowly, while
aldosterone slightly decreased only two hours after the end of
albumin infusion and without reaching significant differences
from baseline values (Fig. 2A, right column). At the end of
albumin infusion, Cr, Cosm, CH,o, FeNa and proteinuria were
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Table 1. The aldosterone/ANP ratio and solutes and water cxcretion in PE versus normal pregnancy (NP) at the same gestational age
25—29 weeks 30—34 weeks >35 weeks
NP PE
N=32 N=5NP PEN=32 N=6 NP
PE
N=32 N=7
Aldosterone pg/mi
ANP pg/mi
Aldosterone/ANP ratio
UNUV mmoi/24 hr
UKV mmol/24 hr
FENa %
Coam mi/mm
CH,O mi/mm
669 302 113 651)
35 7 31 12
19.1 6 4.6 38b
189 64 104 33
62 23 32.9 9,7a
0.57 0.18 0.56 0.35
2.15 0.71 1.17 0.70a
—1.11 0.52 —0.49 019b
741 323 194 116"
33.3 9 35.1 12
21.4 7 6.2 3,5b
177 74 96 28
50 18 38.6 9.1
0.57 0.14 0.37 0.15a
2.07 0.57 1.51 0.30a
—1.08 0.5 —0.64 0,44a
845 449 285 l90'
29.5 4.8 25.4 6.1
28.7 12 11.5 7,0b
195 103 79 46
55 24 43.5 45
0.60 0.20 0.27 0.I7
2.75 0.70 1,53 o.7o
—1.05 0.5 —0.43 0.12
a p < 0.05, PB vs. NP
b P <0.01, PE vs. NP
significantly increased in the responders, but all these changes
were reduced or disappeared two hours after (Fig. 2B, left
column). In the non-responders, Ce,., Cosm and proteinuria
were even reduced at the end of the albumin infusion (Fig. 2B,
right column). Before albumin infusion, the responders differed
significantly from the non-responders in their lower ANP (P <
0.05), higher aldosterone and aldosterone/ANP ratio (P < 0.01),
lower urine volume and excretion of solutes (P < 0.01) and
proteinuria (P < 0.05). No significant differences were observed
between the responders and non-responders in serum creatinine
(0.8 0.2 and 0.7 0.3 mg/dl) and albumin levels (29 10 and
30 11 g/liter), uric acid concentration (6 2 mg/dl and 5.9
2 mg/dl) and platelet count (181 60 and 243 90 x 109/liter).
One case of preexisting nephropathy resulted in the responders
group, and one case of previous PE in the non-responders
group. In this acute volume loading test, neither group of
patients demonstrated a change in blood pressure. No statistical
differences were observed in pre-albumin blood pressure values
in responder (171 12 mm Hg systolic, 106 8 mm Hg
diastolic) and non-responder (169 13 mm Hg systolic, 105
9 mm Hg diastolic) patients. There were no significant correla-
tions between ANP, aldosterone by itself and solutes excretion
in samples of 24 hour urine, but there was a significant inverse
correlation between the aldosterone/ANP ratio and total so-
dium excretion in the samples collected before albumin infusion
in all patients. In the responders, the correlation between the
ratio and sodium excretion was maintained even at the end of
the albumin infusion and two hours post-infusion (Fig. 3).
Since the result showed the responders to be all confined to a
group with a prealbumin ratio greater than the value of six, we
compared PE among two subgroups on the basis of the ratio
below and above the value of six (excluding two patients who
delivered in other cities; Table 2). The patients of the two
groups were not significantly different in terms of severity of
disease, (evaluated by blood pressure, proteinuria, creatinine
and serum uric acid levels). In the group with the lowest ratio
there was a significantly greater number of cases with patho-
logical fetoplacental flow, significantly lower APGAR values,
and significantly more cases of infants who where small for their
gestational ages.
Discussion
In normal pregnancy, according to the overfill hypothesis
primary renal sodium retention with expansion of extracellular
fluid and consequent enhanced renal hemodynamics occurs.
Alternatively, the increased activation of the renin-angiotensin-
aldosterone system and the lower osmotic thresholds for ADH
release are the main elements supporting the underifil hypoth-
esis of a primary vasodilation with secondary renal sodium and
water retention [1, 20]. In this latter hypothesis, the marked
increase in aldosterone levels hardly seems to be sufficient to
counteract enhanced natriuretic forces in order to maintain
adequate volume. The results of our serial study, showing low
or normal ANP value in physiological pregnancy, are in accor-
dance with previous results both in pregnant animals [1, 20] and
in humans [8, 9, 12], and seem to confirm the hypothesis that
the new volume condition is perceived by volume receptors as
hypovolemic in an early phase and normovolemic in the subse-
quent months. It is possible that compartimentalization of fluids
and/or vasodilation are responsible for what actually is an only
moderate increase of atrial pressure. In effect, previous reports
showed higher concentrations of vasodilating factors in early
and late pregnancy [21], at the same times when we found
relatively lower ANP values. However, other authors reported
increased ANP values in cross sectional studies both in the first
and in the last trimester of normal pregnancy [7, 10, 15, 16],
though ANP levels did not prove to correlate with the known
changes in blood volume [10]. These different results are
probably due to the different methods employed, including
different procedures both in the antibody production and in
blood sample handling. Since control references report levels of
circulating ANP immunoreactivity ranging from 2 to 100 pg/mI,
it is obvious that up to now we are measuring ANP in different
forms, not necessarily reflecting biological activity [22—24],
because unprocessed precursor peptides and/or degradation
products may cross react with the antibody to a different degree
depending on the method employed. In general, with the
extraction technique, it remains uncertain how much of the
variety of circulating natriuretic peptides is effectively ex-
tracted. Conversely, without the extraction technique, if anti-
serum sensitivity is not sufficiently high, changes in ANP
concentrations may prove to be flattened. Definitive progress in
this field will be achieved only by standardized procedures
including monoclonal antibody use specific to active peptides
only.
We can argue from our results that in normal pregnancy the
aldosterone/ANP ratio shows that the highest values in favor of
the water-sodium-saving forces are in early and late pregnancy,
obviously in the same periods in which there is a maximum
dissociation between the behavior of aldosterone and ANP. It is
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Fig. 2A. Aldosterone, ANP, aldosterone/ANP ratio, urinary volume (Uk) and sodium (UNV) and potassium (UKV) excretion in responder (N =
6) and non-responder (N = 6)preeclamptic patients to albumin infusion. Abbreviations are: T0 =before albumin infusion; T1 = at the end of the
albumin infusion; T2 = 2 hr after the end of albumin infusion. *P < 0.05 T1 vs. T0. B Creatinine clearance (Car), osmolar clearance (Com), free
water clearance (CH2O); FENa and proteinuria in responder (N = 6) and non responder (N = 6) preeclamptic patients to albumin infusion.
Abbreviations are: T0, before albumin infusion; T, at the end of albumin infusion; T2, 2 hr after the end of albumin infusion. *P < 0.05 T1 vs.
To.
hormones seem to be able to indicate the moment of the
maximum effort to gain and to maintain volume. During gesta-
tion there is a cumulative retention of approximately 900 mEq
of sodium, but the quantity retained (2 to 6 mEq/day) is too
small to be detected by conventional balance techniques [24]. In aldosterone. In this connection, an only moderate increase in
fact, the fractional sodium excretion is still within normal ANP concentration could help to avoid water and sodium
ranges and near constant for all the duration of the pregnancy
and in the early puerpuerium, but the aldosterone/ANP ratio in
pregnancy is always 5 to 10 times higher with respect to
postpartum values. This data suggests that adequate sodium
and volume conservation in pregnancy is dependent upon the
capacity to increase several-fold the extent of the bias in favor
of the most important antinatriuretic factors represented by
interesting to observe that late pregnancy is reported to be the
period of most rapid sodium accumulation [25], and therefore,
the aldosterone by itself and the relationship between the two
A B
80
60
40
20
300
200
100
10
7.5
5
2.5
200
150
EL 100
>D
50
250
1200
1000
50
0
4.0
2.0
—0.5
-1.0
EL —1.50
-200
—2.5
0.80
0.60
Jo.40LI-
0.20
5.0
4.0
> 3.0
2.0
1.0
D 0.5
200
150
100
50
100
75
50
25
T0 T, T2 T T
Responders Non-responders Responders Non-responders
10 11 I T0 T1 T2
912 Stratta et a!: Aldosterone and ANP in pregnancy
3
Aldosterone/ANP ratio
Table 2. Placental flows and fetal outcome in preeclamptic
with lowest and highest aldosterone/ANP ratio
patients
Aldosterone ANP ratio
P
<6 >6(N=8) (N=8)
Pathological flows (No. of cases)
uteroplacental 7/8 4/8
fetoplacental 8/8 2/8
Apgar at 5 minutes 5.2 2 8.1 1
Infants small for gestational 8/8 3/8
age (No. of cases)
NS
<0.01
<0,05
0.02
wastage in the presence of other natriuretic endogenous forces
that already need a compensatory increment in aldosterone.
In preeclampsia we found reduced aldosterone levels as
described in previous reports [12, 15, 16], and ANP values
ranging from normal to high values. We did not measure plasma
volumes, but previous studies demonstrated reduced intravas-
cular volumes in comparison with normal pregnancy [2—5].
Thus, even ANP values which are not significantly different
from normal pregnancy at the same gestational age prove to be
inappropriately high. Consequently, ANP values in preeclamp-
sia cannot be assumed to be markers of an "effective" intra-
vascular volume state, and the reasons for the increased ANP
release still have to be clarified. Consistent with the postulate
relationship with the renin system, it might be that ANP, which
is also a potent vasorelaxant, could control a kind of safety
valve in inducing compensatory mechanisms following the
increased susceptibility of the vascular bed tO angiotensin II
[17]. However, if this kind of compensatory mechanism is
operating in preeclampsia, it seems to be insufficient for the
normalization of blood pressure and, furthermore, it may con-
tribute to a worsening of preeclampsia. In fact, not only does
ANP antagonize the aldosterone effects on tubular sodium
reabsorption, but it can also promote fluid shifts from the
vascular bed to the extravascular space [6]. If we look at the
Fig. 3. Relationship between the
aldosterone/ANP ratio and sodium excretion
(UNV) in preeclamptic patients before and
after (only for responder) albumin infusion.
Symbols are: (U) T0, before albumin
infusion; (U) T1, at the end of albumin
infusion; (•) T2, 2 hr after the end of
albumin infusion.
ratio between aldosterone and ANP, we can offer an explana-
tion for the puzzling paradox emerging from previous reports,
which show that the most severe preeclampsia is associated
both with higher ANP levels [13] and lower intravascular
volumes [5]. In fact, the more ANP is increased, the more the
bias in favor of aldosterone in the balance between aldosterone
and ANP is reduced, thus further impairing the already reduced
ability of water-sodium-saving forces to increase volume.
In conclusion, a significantly lower aldosterone/ANP ratio is
compatible with both a sodium wastage and failure of water-
sodium-saving factors to expand maternal volume adequately in
preeclampsia. It is true that ANP or aldosterone could be
predictors by themselves, but because it seems likely that ANP
and the renin axis collaborate in a continuing basis in regulating
volume homeostasis, the relationship between the two hor-
mones may offer further insights.
The results of our study confirm first of all the relationship
between lower aldosterone/ANP ratio and higher sodium excre-
tion in PE, and secondly suggest a possible relationship be-
tween this ratio and the volume state.
In fact, among preeclamptic patients, a particularly low
aldosterone/ANP ratio in early cases is associated with rela-
tively higher sodium and lower potassium excretion in accor-
dance with a condition of particularly severe aldosterone defi-
ciency with respect to the natriuretic factors. Furthermore, a
significant inverse relationship is observed in preeclampsia
between the aldosterone/ANP ratio and sodium excretion be-
fore and after albumin in the responder patients by using urine
samples collected near the time of blood determinations (and
not urine samples of 24 hours). This is probably because diurnal
changes both in aldosterone and ANP reduce the relationship
between pooled 24-hour urine collections and the ratio [16]. It is
clear that correlations do not establish causality, and we cannot
exclude the possibility that natriuresis may be due to other
factors, because of the myriad of other hormones and neural
influences that can modulate renal function [15, 26, 27]. How-
ever, the post-albumin natriuresis of the responders whose ratio
0 2 4 6 8 10
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is further decreased following the infusion confirms that a lower
ratio may account for a higher sodium excretion. Since a lower
ratio and the associated increased natriuresis seems to be
detrimental in the volume-contracted-state of preeclampsia, the
fact that these same results may be achieved following albumin
infusion should be regarded as useful in this context only
assuming that albumin may act as a true "extravascular diuret-
ic", by promoting excretion of fluids and solutes shifted from
interstitial spaces to the intravascular compartment.
A putative relationship between the aldosterone/ANP ratio
and the volume state could be suggested by the observation that
the preeclamptic patients who failed to have a post-albumin
natriuresis showed a significantly lower pre-albumin ratio. This
condition resembles that of the markedly suppressed natriuresis
in the isolated kidney after long-term sodium restriction [re-
viewed in 17]. Since it has been postulated that a reduced
effective circulation may be responsible for the increased so-
dium avidity of the kidney, it is thus possible that, following the
renal de-adaptation, an acute increment in effective circulation
is unable to give a large sodium excretion within a few hours in
severe volume-depleted cases. If such renal de-adaptation is
present to some degree in our non-responder patients, and
re-adaptation during intravascular expansion is a slow phenom-
enon, a more prolonged or a repeated expansion may be
necessary to induce substantial natriuresis in particularly hy-
povolemic conditions. In partial confirmation of this assump-
tion, we observed an increased natriuresis in two out of three of
the non-responder patients after repeating albumin infusion in
the afternoon or in the following days (data not shown).
Lastly, the possibility that in these settings a particularly low
ratio identifies patients with extremely reduced volumes, is
further supported by the observation that in this subgroup there
are more cases with reduced placental flow and infants small for
gestational age. In fact, previous reports demonstrated that a
low weight at birth in preeclampsia is significantly related to
more severe intravascular volume contraction [4].
In conclusion, we have demonstrated that the differential
between aldosterone and ANP is 5 to 10 times higher in normal
pregnancy compared to non-pregnant values in order to main-
tain a constant sodium balance. The ratio shows a maximum
bias in favor of aldosterone in the early and late phases of
normal pregnancy, while the bias in favor of aldosterone is
considerably reduced in preeclamptic patients. A particularly
low aldosterone/ANP ratio in preeclampsia correlates with a
relatively higher sodium excretion, and it may be used to
identify patients who are unable to respond to albumin infusion
perhaps as a consequence of greatly reduced intravascular
volumes.
It is intriguing to hypothesize that the balance between
aldosterone and ANP may potentiate the significance of aldo-
sterone and ANP alone in understanding sodium handling and,
perhaps, volume changes in these settings, by indicating the
actual balance between two main sodium saving and sodium
wasting factors.
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